This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.

Browse

5-MeO-DMT

Short-acting tryptamine ("the God molecule").

Aliases (8)
5-methoxy-N · N-dimethyltryptamine · Bufo · Bufo alvarius · Sonoran Desert toad · Colorado River toad · Mebufotenin · the God molecule
TYPICAL DOSE
ROUTE
CYCLE
STORAGE

Overview

What is 5-MeO-DMT?

Short-acting tryptamine ("the God molecule"). 5-HT1A-dominant ego-dissolution experience. GH Research Phase 2 in TRD showed single-dose 87% remission. SKIP-PERMANENT outside structured clinical context — experience intensity exceeds what most users can integrate unsupported.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources